Business Context and Reporting Period
Company: Ocular Therapeutix, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 10, 2015
Reporting Period: Quarter and year ended December 31, 2014
This filing serves as a notification that the Company announced its financial results for the specified period. The detailed results are contained in a press release furnished as Exhibit 99.1 and incorporated by reference.
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being included in the attached press release (Exhibit 99.1) but are not present in the body of this Form 8-K.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. It only confirms the announcement of results for the quarter and year ended December 31, 2014.
Guidance, Outlook, and Risks
The text does not include specific guidance, outlook, management commentary, risks, contingencies, or unusual items. It states that the information is furnished to comply with Item 2.02 and is not deemed "filed" for purposes of Section 18 of the Exchange Act, nor incorporated by reference in other filings except as expressly set forth.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated March 10, 2015) for actual financial figures.
- Verify the specific revenue and net loss figures for the quarter and year ended December 31, 2014.
- Check the press release for cash position, burn rate, and liquidity runway.
- Confirm any updates on clinical trial progress or regulatory milestones mentioned in the full press release.
- Review the full text for any forward-looking statements or risk factors not summarized in this 8-K.